Global Amifostine Market Research Report 2026(Status and Outlook)

May 2026 | 127 pages | ID: G5565624C4A2EN
Bosson Research

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Amifostine competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen under the trade name Ethyol. In 2024, global Amifostine production reached approximately 4.68 M unit, with an average global market price of around US$ 22 per unit.The amifostine market is primarily shaped by its role as a cytoprotective agent used alongside chemotherapy and radiotherapy to reduce toxic side effects such as xerostomia and myelosuppression. Its clinical application is most notable in cancer care, particularly for head and neck cancers, though off-label exploration in other areas has also contributed to steady demand. The growing incidence of cancer worldwide, coupled with the rising adoption of supportive care therapies, supports market expansion. Additionally, increasing awareness of treatment-related quality-of-life issues and hospital protocols emphasizing patient safety have sustained the relevance of amifostine in oncology.At the same time, the market faces headwinds from high treatment costs, limited availability in some regions, and the emergence of alternative protective agents or treatment regimens with fewer side effects. Patent expiries and the entry of generics have led to greater price competition, particularly in emerging markets where affordability drives uptake. Opportunities lie in expanding access through generics, advancing formulations to reduce adverse reactions such as hypotension and nausea, and integrating amifostine into broader supportive oncology care strategies. Overall, while niche compared to mainstream oncology drugs, the amifostine market remains stable, supported by its unique protective benefits in cancer treatment.

The global Amifostine market size was estimated at USD 52.1 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 2.10% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Amifostine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Amifostine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Amifostine market.

Global Amifostine Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

  • Clinigen
  • Sun Pharmaceutical
  • Taj Pharmaceuticals
  • Merro Pharmaceutical
  • Luye Pharma
  • Mingren Pharma

Market Segmentation (by Type)

  • 400mg/Dose
  • 500mg/Dose

Market Segmentation (by Application)

  • Head and Neck Cancer Adjuvant Therapy
  • Others

Geographic Segmentation

  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Amifostine Market

Overview of the regional outlook of the Amifostine Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Amifostine Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Amifostine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Amifostine
1.2 Key Market Segments
  1.2.1 Amifostine Segment by Type
  1.2.2 Amifostine Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 AMIFOSTINE MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Amifostine Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Amifostine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 AMIFOSTINE MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Amifostine Product Life Cycle
3.3 Global Amifostine Sales by Manufacturers (2020-2025)
3.4 Global Amifostine Revenue Market Share by Manufacturers (2020-2025)
3.5 Amifostine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Amifostine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Amifostine Market Competitive Situation and Trends
  3.8.1 Amifostine Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Amifostine Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 AMIFOSTINE INDUSTRY CHAIN ANALYSIS

4.1 Amifostine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF AMIFOSTINE MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Amifostine Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy – April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Amifostine Market
5.7 ESG Ratings of Leading Companies

6 AMIFOSTINE MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Amifostine Sales Market Share by Type (2020-2025)
6.3 Global Amifostine Market Size by Type (2020-2025)
6.4 Global Amifostine Price by Type (2020-2025)

7 AMIFOSTINE MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Amifostine Market Sales by Application (2020-2025)
7.3 Global Amifostine Market Size (M USD) by Application (2020-2025)
7.4 Global Amifostine Sales Growth Rate by Application (2020-2025)

8 AMIFOSTINE MARKET SALES BY REGION

8.1 Global Amifostine Sales by Region
  8.1.1 Global Amifostine Sales by Region
  8.1.2 Global Amifostine Sales Market Share by Region
8.2 Global Amifostine Market Size by Region
  8.2.1 Global Amifostine Market Size by Region
  8.2.2 Global Amifostine Market Size by Region
8.3 North America
  8.3.1 North America Amifostine Sales by Country
  8.3.2 North America Amifostine Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Amifostine Sales by Country
  8.4.2 Europe Amifostine Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Amifostine Sales by Region
  8.5.2 Asia Pacific Amifostine Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Amifostine Sales by Country
  8.6.2 South America Amifostine Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Amifostine Sales by Region
  8.7.2 Middle East and Africa Amifostine Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 AMIFOSTINE MARKET PRODUCTION BY REGION

9.1 Global Production of Amifostine by Region(2020-2025)
9.2 Global Amifostine Revenue Market Share by Region (2020-2025)
9.3 Global Amifostine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Amifostine Production
  9.4.1 North America Amifostine Production Growth Rate (2020-2025)
  9.4.2 North America Amifostine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Amifostine Production
  9.5.1 Europe Amifostine Production Growth Rate (2020-2025)
  9.5.2 Europe Amifostine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Amifostine Production (2020-2025)
  9.6.1 Japan Amifostine Production Growth Rate (2020-2025)
  9.6.2 Japan Amifostine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Amifostine Production (2020-2025)
  9.7.1 China Amifostine Production Growth Rate (2020-2025)
  9.7.2 China Amifostine Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Clinigen
  10.1.1 Clinigen Basic Information
  10.1.2 Clinigen Amifostine Product Overview
  10.1.3 Clinigen Amifostine Product Market Performance
  10.1.4 Clinigen Business Overview
  10.1.5 Clinigen SWOT Analysis
  10.1.6 Clinigen Recent Developments
10.2 Sun Pharmaceutical
  10.2.1 Sun Pharmaceutical Basic Information
  10.2.2 Sun Pharmaceutical Amifostine Product Overview
  10.2.3 Sun Pharmaceutical Amifostine Product Market Performance
  10.2.4 Sun Pharmaceutical Business Overview
  10.2.5 Sun Pharmaceutical SWOT Analysis
  10.2.6 Sun Pharmaceutical Recent Developments
10.3 Taj Pharmaceuticals
  10.3.1 Taj Pharmaceuticals Basic Information
  10.3.2 Taj Pharmaceuticals Amifostine Product Overview
  10.3.3 Taj Pharmaceuticals Amifostine Product Market Performance
  10.3.4 Taj Pharmaceuticals Business Overview
  10.3.5 Taj Pharmaceuticals SWOT Analysis
  10.3.6 Taj Pharmaceuticals Recent Developments
10.4 Merro Pharmaceutical
  10.4.1 Merro Pharmaceutical Basic Information
  10.4.2 Merro Pharmaceutical Amifostine Product Overview
  10.4.3 Merro Pharmaceutical Amifostine Product Market Performance
  10.4.4 Merro Pharmaceutical Business Overview
  10.4.5 Merro Pharmaceutical Recent Developments
10.5 Luye Pharma
  10.5.1 Luye Pharma Basic Information
  10.5.2 Luye Pharma Amifostine Product Overview
  10.5.3 Luye Pharma Amifostine Product Market Performance
  10.5.4 Luye Pharma Business Overview
  10.5.5 Luye Pharma Recent Developments
10.6 Mingren Pharma
  10.6.1 Mingren Pharma Basic Information
  10.6.2 Mingren Pharma Amifostine Product Overview
  10.6.3 Mingren Pharma Amifostine Product Market Performance
  10.6.4 Mingren Pharma Business Overview
  10.6.5 Mingren Pharma Recent Developments

11 AMIFOSTINE MARKET FORECAST BY REGION

11.1 Global Amifostine Market Size Forecast
11.2 Global Amifostine Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Amifostine Market Size Forecast by Country
  11.2.3 Asia Pacific Amifostine Market Size Forecast by Region
  11.2.4 South America Amifostine Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Amifostine by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Amifostine Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Amifostine by Type (2026-2035)
  12.1.2 Global Amifostine Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Amifostine by Type (2026-2035)
12.2 Global Amifostine Market Forecast by Application (2026-2035)
  12.2.1 Global Amifostine Sales (K MT) Forecast by Application
  12.2.2 Global Amifostine Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Amifostine Market Size by Type (M USD)
Table 4. Global Amifostine Market Size by Application
Table 5. Amifostine Market Size Comparison by Region (M USD)
Table 6. Global Amifostine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Amifostine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Amifostine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Amifostine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amifostine as of 2025)
Table 11. Global Market Amifostine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Amifostine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Amifostine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Amifostine Sales by Type (K MT)
Table 27. Global Amifostine Market Size by Type (M USD)
Table 28. Global Amifostine Sales (K MT) by Type (2020-2025)
Table 29. Global Amifostine Sales Market Share by Type (2020-2025)
Table 30. Global Amifostine Market Size (M USD) by Type (2020-2025)
Table 31. Global Amifostine Market Share by Type (2020-2025)
Table 32. Global Amifostine Price (USD/KG) by Type (2020-2025)
Table 33. Global Amifostine Sales (K MT) by Application
Table 34. Global Amifostine Market Size by Application
Table 35. Global Amifostine Sales by Application (2020-2025) & (K MT)
Table 36. Global Amifostine Sales Market Share by Application (2020-2025)
Table 37. Global Amifostine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Amifostine Market Share by Application (2020-2025)
Table 39. Global Amifostine Sales Growth Rate by Application (2020-2025)
Table 40. Global Amifostine Sales by Region (2020-2025) & (K MT)
Table 41. Global Amifostine Sales Market Share by Region (2020-2025)
Table 42. Global Amifostine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Amifostine Market Size by Region (2020-2025)
Table 44. North America Amifostine Sales by Country (2020-2025) & (K MT)
Table 45. North America Amifostine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Amifostine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Amifostine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Amifostine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Amifostine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Amifostine Sales by Country (2020-2025) & (K MT)
Table 51. South America Amifostine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Amifostine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Amifostine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Amifostine Production (K MT) by Region(2020-2025)
Table 55. Global Amifostine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Amifostine Revenue Market Share by Region (2020-2025)
Table 57. Global Amifostine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Amifostine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Amifostine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Amifostine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Amifostine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Clinigen Basic Information
Table 63. Clinigen Amifostine Product Overview
Table 64. Clinigen Amifostine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Clinigen Business Overview
Table 66. Clinigen SWOT Analysis
Table 67. Clinigen Recent Developments
Table 68. Sun Pharmaceutical Basic Information
Table 69. Sun Pharmaceutical Amifostine Product Overview
Table 70. Sun Pharmaceutical Amifostine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Sun Pharmaceutical Business Overview
Table 72. Sun Pharmaceutical SWOT Analysis
Table 73. Sun Pharmaceutical Recent Developments
Table 74. Taj Pharmaceuticals Basic Information
Table 75. Taj Pharmaceuticals Amifostine Product Overview
Table 76. Taj Pharmaceuticals Amifostine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Taj Pharmaceuticals Business Overview
Table 78. Taj Pharmaceuticals SWOT Analysis
Table 79. Taj Pharmaceuticals Recent Developments
Table 80. Merro Pharmaceutical Basic Information
Table 81. Merro Pharmaceutical Amifostine Product Overview
Table 82. Merro Pharmaceutical Amifostine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Merro Pharmaceutical Business Overview
Table 84. Merro Pharmaceutical Recent Developments
Table 85. Luye Pharma Basic Information
Table 86. Luye Pharma Amifostine Product Overview
Table 87. Luye Pharma Amifostine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Luye Pharma Business Overview
Table 89. Luye Pharma Recent Developments
Table 90. Mingren Pharma Basic Information
Table 91. Mingren Pharma Amifostine Product Overview
Table 92. Mingren Pharma Amifostine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Mingren Pharma Business Overview
Table 94. Mingren Pharma Recent Developments
Table 95. Global Amifostine Sales Forecast by Region (2026-2035) & (K MT)
Table 96. Global Amifostine Market Size Forecast by Region (2026-2035) & (M USD)
Table 97. North America Amifostine Sales Forecast by Country (2026-2035) & (K MT)
Table 98. North America Amifostine Market Size Forecast by Country (2026-2035) & (M USD)
Table 99. Europe Amifostine Sales Forecast by Country (2026-2035) & (K MT)
Table 100. Europe Amifostine Market Size Forecast by Country (2026-2035) & (M USD)
Table 101. Asia Pacific Amifostine Sales Forecast by Region (2026-2035) & (K MT)
Table 102. Asia Pacific Amifostine Market Size Forecast by Region (2026-2035) & (M USD)
Table 103. South America Amifostine Sales Forecast by Country (2026-2035) & (K MT)
Table 104. South America Amifostine Market Size Forecast by Country (2026-2035) & (M USD)
Table 105. Middle East and Africa Amifostine Sales Forecast by Country (2026-2035) & (Units)
Table 106. Middle East and Africa Amifostine Market Size Forecast by Country (2026-2035) & (M USD)
Table 107. Global Amifostine Sales Forecast by Type (2026-2035) & (K MT)
Table 108. Global Amifostine Market Size Forecast by Type (2026-2035) & (M USD)
Table 109. Global Amifostine Price Forecast by Type (2026-2035) & (USD/KG)
Table 110. Global Amifostine Sales (K MT) Forecast by Application (2026-2035)
Table 111. Global Amifostine Market Size Forecast by Application (2026-2035) & (M USD)

LIST OF FIGURES

Figure 1. Product Picture of Amifostine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Amifostine Market Size (M USD), 2025-2035
Figure 5. Global Amifostine Market Size (M USD) (2020-2035)
Figure 6. Global Amifostine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Amifostine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Amifostine Product Life Cycle
Figure 13. Amifostine Sales Share by Manufacturers in 2025
Figure 14. Global Amifostine Revenue Share by Manufacturers in 2025
Figure 15. Amifostine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Amifostine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Amifostine Revenue in 2025
Figure 18. Industry Chain Map of Amifostine
Figure 19. Global Amifostine Market PEST Analysis
Figure 20. Global Amifostine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Amifostine Market Share by Type
Figure 27. Sales Market Share of Amifostine by Type (2020-2025)
Figure 28. Sales Market Share of Amifostine by Type in 2025
Figure 29. Market Share of Amifostine by Type (2020-2025)
Figure 30. Market Share of Amifostine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Amifostine Market Share by Application
Figure 33. Global Amifostine Sales Market Share by Application (2020-2025)
Figure 34. Global Amifostine Sales Market Share by Application in 2025
Figure 35. Global Amifostine Market Share by Application (2020-2025)
Figure 36. Global Amifostine Market Share by Application in 2025
Figure 37. Global Amifostine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Amifostine Sales Market Share by Region (2020-2025)
Figure 39. Global Amifostine Market Size by Region (2020-2025)
Figure 40. North America Amifostine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Amifostine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Amifostine Sales Market Share by Country in 2024
Figure 43. North America Amifostine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Amifostine Market Size by Country in 2024
Figure 45. U.S. Amifostine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Amifostine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Amifostine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Amifostine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Amifostine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Amifostine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Amifostine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Amifostine Sales Market Share by Country in 2024
Figure 53. Europe Amifostine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Amifostine Market Size by Country in 2024
Figure 55. Germany Amifostine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Amifostine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Amifostine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Amifostine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Amifostine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Amifostine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Amifostine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Amifostine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Amifostine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Amifostine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Amifostine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Amifostine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Amifostine Market Size by Region in 2024
Figure 68. China Amifostine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Amifostine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Amifostine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Amifostine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Amifostine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Amifostine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Amifostine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Amifostine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Amifostine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Amifostine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Amifostine Sales and Growth Rate (K MT)
Figure 79. South America Amifostine Sales Market Share by Country in 2024
Figure 80. South America Amifostine Market Size and Growth Rate (M USD)
Figure 81. South America Amifostine Market Size by Country in 2024
Figure 82. Brazil Amifostine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Amifostine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Amifostine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Amifostine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Amifostine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Amifostine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Amifostine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Amifostine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Amifostine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Amifostine Market Size by Region in 2024
Figure 92. Saudi Arabia Amifostine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Amifostine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Amifostine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Amifostine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Amifostine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Amifostine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Amifostine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Amifostine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Amifostine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Amifostine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Amifostine Production Market Share by Region (2020-2025)
Figure 103. North America Amifostine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Amifostine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Amifostine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Amifostine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Amifostine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Amifostine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Amifostine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Amifostine Market Share Forecast by Type (2026-2035)
Figure 111. Global Amifostine Sales Forecast by Application (2026-2035)
Figure 112. Global Amifostine Market Share Forecast by Application (2026-2035)